Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Rang in aandelen #210
Boston Scientific Corporation develops, manufactures, and markets medical... Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Aandeelprijs
$62.83
Marktkapitalisatie
$93.23B
Verandering (1 dag)
-9.17%
Verandering (1 jaar)
-31.36%
Land
US
Handel Boston Scientific Corporation (BSX)

Categorie

Aantal uitstaande aandelen voor Boston Scientific Corporation (BSX)
Aantal uitstaande aandelen per December 2025: 1.48B
Volgens de laatste financiële rapporten en de aandelenkoers van Boston Scientific Corporation bedraagt het huidige aantal uitstaande aandelen 1.48B. Aan het einde van December 2024 had het bedrijf 1.47B uitstaande aandelen. Het aantal uitstaande aandelen wordt meestal beïnvloed door aandelensplitsingen en terugkoop van aandelen.
Geschiedenis van uitstaande aandelen van Boston Scientific Corporation (BSX) van 2000 tot 2026
Uitstaande aandelen aan het einde van elk jaar
Jaar Uitstaande aandelen Wijzigen
2026 (TTM) 1.48B 0.16%
2025 1.48B 0.60%
2024 1.47B 1.27%
2023 1.45B 1.57%
2022 1.43B 0.58%
2021 1.42B 0.40%
2020 1.42B 1.81%
2019 1.39B 0.76%
2018 1.38B 0.80%
2017 1.37B 0.92%
2016 1.36B 2.25%
2015 1.33B 0.26%
2014 1.32B -1.26%
2013 1.34B -4.66%
2012 1.41B -6.80%
2011 1.51B -0.56%
2010 1.52B 0.66%
2009 1.51B 0.63%
2008 1.50B 0.78%
2007 1.49B 16.74%
2006 1.27B 54.14%
2005 826.32M -1.18%
2004 836.22M 0.98%
2003 828.07M 2.12%
2002 810.87M -2.40%
2001 830.77M 2.45%
2000 810.87M 0.00%
Uitstaande aandelen van vergelijkbare bedrijven of concurrenten
Bedrijf Uitstaande aandelen Verschil Land
1.75B 17.83%
US
382.50M -74.20%
US
1.28B -13.50%
IE
1.28B -13.53%
IE
2.23B 50.64%
DE